Biotech · Private company
Sucampo Pharmaceuticals, Inc.
Track this companyFree. Adds Sucampo Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to PlaceboPHASE3 · COMPLETED · started Mar 13, 2017ClinicalTrials.gov NCT03097861 · fetched Nov 12, 2026
- Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)PHASE3 · COMPLETED · started Dec 1, 2010ClinicalTrials.gov NCT01298219 · fetched Nov 12, 2026
- Efficacy and Safety of Cobiprostone in Patients With Portal HypertensionPHASE2 · TERMINATED · started Jul 1, 2008ClinicalTrials.gov NCT00737594 · fetched Nov 12, 2026
- Opioid-induced Bowel Dysfunction: Pivotal Assessment of LubiprostonePHASE3 · COMPLETED · started Aug 1, 2007ClinicalTrials.gov NCT00595946 · fetched Nov 12, 2026
- Opioid-induced Bowel Dysfunction Pivotal Assessment of LubiprostonePHASE3 · COMPLETED · started Aug 1, 2007ClinicalTrials.gov NCT00597428 · fetched Nov 12, 2026
- Safety and Efficacy of Lubiprostone in Pediatric Patients With ConstipationPHASE4 · COMPLETED · started Jan 1, 2007ClinicalTrials.gov NCT00452335 · fetched Nov 12, 2026